The ‘molecular DNA scissor’ CRISPR/Cas9 is a powerful tool in cancer research

6 October 2020

By using the genome-editing technique CRISPR/Cas9, researchers from the research section at the Department of Haematology investigate chemotherapy resistance in cancer cells. Treatment resistance is a major clinical challenge, and by using this technology we aim at improving the understanding of drug resistance, which can hopefully be used to develop more a efficient treatment in the future. Read more here